MA. Johnson

发表

Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population

M. Youle, S. Khoo, C. Smith, 2009, HIV medicine.

Special Issue: British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (2013 update)

C. Leen, A. Winston, C. Sabin, 2014 .

Tenofovir‐associated renal and bone toxicity

A. Copas, S. Edwards, D. Nair, 2009, HIV medicine.

Global HIV‐1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

J. Lundgren, D. Dunn, A. Geretti, 2015, HIV medicine.

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV‐infected subjects

G. Janossy, M. Lipman, MA. Johnson, 2002, HIV medicine.

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease

D. Pillay, M. Youle, B. Gazzard, 1999, HIV medicine.

British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve

H. Curtis, MA. Johnson, E. Street, 2009, HIV medicine.

BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005

R. Miller, S. Collins, S. Lucas, 2005, HIV medicine.

The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000

A. Cozzi-Lepri, MA. Johnson, S. Barry, 2002, HIV medicine.

Changes in hospital admissions across Europe: 1995–2003. Results from the EuroSIDA study

A. Mocroft, O. Kirk, A. Blaxhult, 2004, HIV medicine.

Long‐term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study

C. Leen, D. Pillay, P. Easterbrook, 2011, HIV medicine.

An audit of antiretroviral treatment use in HIV‐infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use

M. Youle, C. Chaloner, M. Lipman, 2003, HIV medicine.

The creation of a large UK‐based multicentre cohort of HIV‐infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

Kholoud Porter, Martin Fisher, Caroline Sabin, 2004, HIV medicine.

Age, time living with diagnosed HIV infection, and self‐rated health

A. Nardone, L. Haddow, R. Gilson, 2016, HIV medicine.

Cardiovascular disease risk factors and antiretroviral therapy in an HIV‐positive UK population

C. Smith, E. Kaya, M. Lipman, 2004, HIV medicine.

Treatment outcomes amongst previously antiretroviral‐naïve HIV‐infected patients starting lopinavir/ritonavir‐containing antiretroviral regimens at the Royal Free Hospital *

M. Youle, C. Smith, M. Tyrer, 2007, HIV medicine.

National review of maternity care for women with HIV infection

A. de Ruiter, M. Johnson, H. Curtis, 2006, HIV medicine.

Findings from the first national clinical audit of treatment for people with HIV

H. Curtis, MA. Johnson, C. Sabin, 2003, HIV medicine.

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997–2003

B. Gazzard, R. Gilson, C. Sabin, 2007, HIV medicine.

Factors associated with viral rebound among highly treatment‐experienced HIV‐positive patients who have achieved viral suppression

S. Staszewski, M. Youle, C. Smith, 2009, HIV medicine.

The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV

R. Ojha, M. Cvitanovich, MA. Johnson, 2021, HIV medicine.

Changing treatment patterns among patients with HIV: Royal Free Hospital 1987–97

C. Sabin, A. Phillips, M. Youle, 1999, HIV medicine.

Participation in clinical studies among patients infected with HIV‐1 in a single treatment centre over 12 years

A. Mocroft, A. Phillips, M. Youle, 2000, HIV medicine.